Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people taking Mounjaro lose a stone within 8 to 12 weeks, though the exact timeline depends on starting weight, the dose reached, and how closely a reduced-calorie diet is followed alongside treatment. Clinical trial data show average losses of around 20–21% of body weight over 72 weeks at the highest dose, meaning a stone is typically just an early milestone. Mounjaro (tirzepatide) is a prescription-only medicine; a qualified prescriber must assess your suitability before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The clearest picture comes from SURMOUNT-1, a 72-week phase 3 trial of tirzepatide published in the New England Journal of Medicine, which enrolled 2,539 adults with obesity. At the 15mg maintenance dose, participants lost roughly 20–21% of body weight on average. For someone starting at 14 stone, that is approaching three stone over the full study period — which puts a single stone firmly in the first quarter of the journey for many participants.
Early data points from the trial show meaningful weight loss appearing within the first four to eight weeks, even at lower doses. The rate tends to steepen once the dose climbs past the initial 2.5mg and 5mg steps, because the appetite-suppressing effect strengthens with each increase. That is not a flaw in the design; the starter dose is there to let your digestive system adjust, not to produce rapid loss from week one.
So a realistic answer for losing a stone is roughly 8–12 weeks for people who start at a higher BMI and move through titration without needing to pause. Lighter people or those who stay on a lower maintenance dose may take longer. How quickly Mounjaro starts working in the first weeks is a related question worth reading alongside this.
Mounjaro is prescribed in six strengths (2.5, 5, 7.5, 10, 12.5, and 15mg) and titration typically moves up in four-week steps as directed by your prescriber. This matters for timelines because weight loss at 2.5mg is modest; the therapeutic effect builds as the dose rises. A prescriber may slow titration if side effects appear, which can push the milestone back by a few weeks.
A question our prescribers hear most weeks is whether staying on a lower dose for longer means losing less weight overall. The honest answer is: it can slow progress temporarily, but titrating too fast tends to cause more nausea and vomiting, which is counterproductive. The schedule exists for a clinical reason.
If you are thinking about what a bigger target looks like over a longer period, losing two stone on Mounjaro typically takes four to six months at an effective maintenance dose, though individual variation is wide.
NICE's appraisal of tirzepatide (TA1026) recommends reviewing continuation if less than 5% of body weight is lost after six months at the highest tolerated dose, a useful clinical benchmark for setting expectations early.
Starting weight is probably the biggest single variable. Someone at 18 stone will typically drop a stone faster in absolute weeks than someone at 11 stone, simply because the caloric deficit created by reduced appetite is proportionally larger. Body composition, hormonal factors, sleep quality, stress levels, and how consistently someone follows dietary guidance alongside treatment all shift the timeline too.
Physical activity does not have to be intense to help. Preserving muscle mass through resistance exercise or regular walking matters because Mounjaro reduces overall calorie intake; without enough protein and movement, some of the weight lost can come from lean tissue rather than fat. That affects both how quickly you see results and how you feel day to day.
For context on longer-term targets, the three-stone timeline on Mounjaro covers what the evidence suggests around six to nine months in. People with higher starting weights can find the five-stone trajectory informative for understanding what sustained treatment looks like.
The NHS provides general context on weight management approaches at NHS: obesity treatment, including the role of diet and activity alongside medicine.
A stone in 8–12 weeks is achievable for many people, but it is not a guarantee. Clinical trials report averages across large groups; your result will sit somewhere in the distribution. Some people lose a stone in six weeks; others take sixteen. Both can be clinically appropriate depending on dose, starting point, and adherence.
If you are not seeing any progress after eight weeks on an effective dose, that is worth raising with your prescriber, not just waiting. Equally, if side effects are making it difficult to eat adequately, the answer is usually dose adjustment rather than pushing through. Numbing any of these signals by comparing your week-by-week progress to an average figure is the wrong way to use this data.
Thinking about the cost of sustained treatment is sensible at this stage too. Mounjaro pricing in the UK explains how private treatment is structured and what a full monthly cost typically covers. More detail on the treatment itself is on the Mounjaro overview page.
If the timeline you are considering involves a larger goal, four stone on Mounjaro and the six-stone page walk through what longer treatment periods look like based on the available evidence.
Suitability is always decided by a prescriber, not a calculator. Check your eligibility through a free consultation with our clinical team if you want a picture tailored to your starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.